The inhibition of DYRK1A is an enchanting therapeutic approach for the treatment of cognitive impairment in Down syndrome together with inhibiting tau hyperphosphorylation in Alzheimer’s disease [124]. The gene discussed is DYRK1A; the disease is Down syndrome.